A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

被引:64
|
作者
Mahoney, Christopher E. [1 ]
Pirman, David [1 ]
Chubukov, Victor [1 ]
Sleger, Taryn [1 ]
Hayes, Sebastian [1 ]
Fan, Zi Peng [1 ]
Allen, Eric L. [1 ]
Chen, Ying [2 ]
Huang, Lingling [2 ]
Liu, Meina [2 ]
Zhang, Yingjia [2 ]
McDonald, Gabrielle [1 ]
Narayanaswamy, Rohini [1 ]
Choe, Sung [1 ]
Chen, Yue [1 ]
Gross, Stefan [1 ]
Cianchetta, Giovanni [1 ]
Padyana, Anil K. [1 ]
Murray, Stuart [1 ]
Liu, Wei [1 ]
Marks, Kevin M. [1 ]
Murtie, Joshua [1 ]
Dorsch, Marion [1 ]
Jin, Shengfang [1 ]
Nagaraja, Nelamangala [1 ]
Biller, Scott A. [1 ]
Roddy, Thomas [1 ]
Popovici-Muller, Janeta [1 ,3 ]
Smolen, Gromoslaw A. [1 ,4 ]
机构
[1] Agios Pharmaceut, 88 Sidney St, Cambridge, MA 02139 USA
[2] Shanghai ChemPartner Co Ltd, 998 Halei Rd, Shanghai 201203, Peoples R China
[3] Decibel Therapeut, 1325 Boylston St,Suite 500, Boston, MA 02215 USA
[4] Celsius Therapeut, 215 First St, Cambridge, MA 02142 USA
关键词
SQUALENE EPOXIDASE; LUNG-CANCER; CHOLESTEROL; METABOLISM; SENSITIVITY; ONCOGENE; ASCL1; LEADS; D2O;
D O I
10.1038/s41467-018-07959-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aberrant metabolism of cancer cells is well appreciated, but the identification of cancer subsets with specific metabolic vulnerabilities remains challenging. We conducted a chemical biology screen and identified a subset of neuroendocrine tumors displaying a striking pattern of sensitivity to inhibition of the cholesterol biosynthetic pathway enzyme squalene epoxidase (SQLE). Using a variety of orthogonal approaches, we demonstrate that sensitivity to SQLE inhibition results not from cholesterol biosynthesis pathway inhibition, but rather surprisingly from the specific and toxic accumulation of the SQLE substrate, squalene. These findings highlight SQLE as a potential therapeutic target in a subset of neuroendocrine tumors, particularly small cell lung cancers.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Chemical Biology Screening Identifies a Vulnerability to Checkpoint Kinase Inhibitors in TSC2-Deficient Renal Angiomyolipomas
    Vaughan, Robert M.
    Kordich, Jennifer J.
    Chan, Chun-Yuan
    Sasi, Nanda K.
    Celano, Stephanie L.
    Sisson, Kellie A.
    Van Baren, Megan
    Kortus, Matthew G.
    Aguiar, Dean J.
    Martin, Katie R.
    MacKeigan, Jeffrey P.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] A genetic screen in Drosophila for synthetic lethality in cancer cells identifies AMPK activators
    Kakemura, Bungo
    Igaki, Tatsushi
    CANCER SCIENCE, 2023, 114 : 2059 - 2059
  • [23] A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells
    Orang, Ayla
    Ali, Saira R.
    Petersen, Janni
    McKinnon, Ross A.
    Aloia, Amanda L.
    Michael, Michael Z.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] A functional screen with metformin identifies microRNAs that regulate metabolism in colorectal cancer cells
    Ayla Orang
    Saira R. Ali
    Janni Petersen
    Ross A. McKinnon
    Amanda L. Aloia
    Michael Z. Michael
    Scientific Reports, 12
  • [25] A high-throughput screen identifies inhibitors of lung cancer stem cells
    She, Xiaofei
    Gao, Yaqun
    Zhao, Yan
    Yin, Yue
    Dong, Zhewen
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 140
  • [26] Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
    Hezhen Shan
    Lingling Geng
    Xiaoyu Jiang
    Moshi Song
    Jianxun Wang
    Zunpeng Liu
    Xiao Zhuo
    Zeming Wu
    Jianli Hu
    Zhejun Ji
    Si Wang
    Piu Chan
    Jing Qu
    Weiqi Zhang
    GuangHui Liu
    Protein & Cell, 2022, 13 (07) : 532 - 555
  • [27] Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
    Shan, Hezhen
    Geng, Lingling
    Jiang, Xiaoyu
    Song, Moshi
    Wang, Jianxun
    Liu, Zunpeng
    Zhuo, Xiao
    Wu, Zeming
    Hu, Jianli
    Ji, Zhejun
    Wang, Si
    Chan, Piu
    Qu, Jing
    Zhang, Weiqi
    Liu, Guang-Hui
    PROTEIN & CELL, 2022, 13 (07) : 532 - 539
  • [28] GENOME-WIDE LOSS-OF-FUNCTION GENETIC SCREEN IDENTIFIES THE VULNERABILITY OF HBV- INTEGRATED HEPATOMA CELLS
    Fukuoka, Makoto
    Kodama, Takahiro
    Hikita, Hayato
    Sung, Jihyun
    Shimoda, Akiyoshi
    Shigeno, Satoshi
    Murai, Kazuhiro
    Nishio, Akira
    Furuta, Kunimaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2023, 78 : S571 - S571
  • [29] A CHEMICAL GENETICS SCREEN IDENTIFIES NOVEL STEROID INHIBITOR DRUGS THAT INHIBIT THE GROWTH OF GLIOMA STEM CELLS
    Rana, M.
    Ajewung, N.
    Poirier, D.
    Kamnasaran, D.
    NEURO-ONCOLOGY, 2010, 12 : 41 - 41
  • [30] A chemical genetics screen identifies novel steroid inhibitor drugs that inhibit the growth of glioma stem cells
    Kamnasaran, D.
    Poirier, D.
    Rana, M.
    Ajewung, N.
    EJC SUPPLEMENTS, 2010, 8 (05): : 36 - 36